Physician profile
Nara Michaelson
NPI 1023571361
$254,450.65
in general payments reported to CMS, 2019-2025
6 companies · $149K in 2025
The $149K reported for 2025 was more than what 99% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $105K · 2025: $149K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $250K · Consulting Fee: $3,625 · Food and Beverage: $1,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $249,600.00 |
| Consulting Fee | $3,625.00 |
| Food and Beverage | $1,225.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $249,600.00 | 2024-2025 | |
| Genzyme Corporation | $3,870.50 | 2025 | |
| Emd Serono, INC. | $427.27 | 2024-2025 | |
| Genentech, INC. | $220.29 | 2024-2025 | Ocrevus |
| Novartis Pharmaceuticals Corporation | $216.75 | 2025 | |
| Tg Therapeutics, INC. | $115.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nara Michaelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.